Search

Microsatellite instability (MSI) and DNA mismatch repair (MMR) deficiencies can predict Lynch syndrome (LS) across tumor types, according to researchers from Memorial Sloan Kettering Cancer Center (MSK), who presented this retrospective data analysis in a press conference at the annual meeting of the American Society of Clinical Oncology. This finding suggests that LS is linked to more types of cancer than previously thought, prompting a call for germline testing for LS in all individuals with MSI-high (MSI-H)/mismatch repair deficient (MMR-D) tumors.

… Saturday, June 2, 2018 Microsatellite instability (MSI) and DNA mismatch repair (MMR) deficiencies can predict Lynch syndrome (LS) across tumor types, according to researchers from Memorial Sloan Kettering Cancer Center (MSK), who presented this retrospective data analysis in a press conference at the

… Wednesday, August 15, 2018 Summary A woman with an aggressive pituitary tumor responded well to immunotherapy. This successful treatment may lead to a clinical trial testing this approach in more people. Tumors of the pea-size pituitary gland, which sits at the base of the brain and secretes hormones

Research fellow Shaniqua Hayes joined the Jason Lewis Lab at the Sloan Kettering Institute (SKI) and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good vibes” about SKI.

… Friday, September 30, 2022 Research fellow Shaniqua Hayes Shaniqua Hayes joined the Jason Lewis Lab Jason Lewis Lab at the  Sloan Kettering Institute (SKI) Sloan Kettering Institute (SKI)  and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good

In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium (CRIC) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman Cancer Institute, and the Tisch Cancer Center of Mount Sinai Health System.

… Friday, March 6, 2026 In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium ( CRIC ) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman

In contrast with the findings of two international trials, Memorial Sloan Kettering Cancer Center data suggest the standard treatment – primary debulking surgery – may provide better outcomes in select patients when compared to neoadjuvant chemotherapy.

… Friday, September 16, 2016 Due to the lack of effective screening and disease-specific symptoms, ovarian cancer is often diagnosed at an advanced stage, after malignant cells have already spread to the visceral and parietal peritoneum, resulting in peritoneal carcinomatosis characterized by widespread

Memorial Sloan Kettering Cancer Center (MSK) today announced a $50 million gift from Jane and Daniel Och to advance MSK’s cutting-edge patient-care and research.

… Monday, June 9, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced a $50 million gift from Jane and Daniel Och to advance MSK’s cutting-edge patient-care and research. The majority of this gift will go towards supporting the development of MSK’s state-of-the-art cancer care facility, The

Of the estimated 1.5 million people diagnosed with cancer each year in the United States, more than 126,000 are between the ages of 20 and 45. Many young cancer patients want to have children after their treatment is completed, and many will be able to have children naturally at that time. However, some patients will lose their ability to conceive a child without the help of procedures designed to assist with reproduction. Unfortunately, many young patients are not adequately informed of and prepared for the risks to fertility that may accompany cancer and some cancer treatments.

… Thursday, October 1, 2009 Of the estimated 1.5 million people diagnosed with cancer each year in the United States, more than 126,000 are between the ages of 20 and 45. Many young cancer patients want to have children after their treatment is completed, and many will be able to have children naturally

An international collaboration of researchers is advancing precision medicine for men with advanced prostate cancer.

… Thursday, May 21, 2015 An international collaboration of researchers is advancing precision medicine for men with advanced prostate cancer. The researchers, led by Arul Chinnaiyan, MD, PhD, and Charles L. Sawyers, MD, co-leaders of the Stand Up to Cancer-Prostate Cancer Foundation Dream Team, sequenced

Memorial Sloan Kettering Cancer Center (MSK) experts presented breakthrough findings in several areas of cancer research at the 2022 Annual ASCO meeting, focusing on rectal, breast, leptomeningeal metastasis, pancreatic, and lung cancers.

… Thursday, June 9, 2022 Memorial Sloan Kettering Cancer Center (MSK) experts presented breakthrough findings in several areas of cancer research at the 2022 ASCO Annual Meeting held June 3 to 7, 2022. Highlights of practice-changing study results in rectal cancer, breast cancer, leptomeningeal metastasis

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Tuesday, March 15, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Atefeh Riazi Named 2022 Healthcare Information and Management Systems Society (HIMSS) Most Influential Women in Health IT Award Recipient Atefeh Riazi Atefeh “Atti” Riazi , Senior Vice